---
title: "Indo US Bio-Tech Ltd (INDOUS) — Share Price, Financials & Analysis"
symbol: "INDOUS"
company: "Indo US Bio-Tech Ltd"
canonical: "https://tapetide.com/stocks/INDOUS"
isin: "INE250Z01010"
nse_symbol: "INDOUS"
bse_code: "541304"
sector: "FMCG"
industry: "Agricultural Products"
market_cap_cr: 158.81
generated_at: "2026-09-13T18:45:30.271Z"
---

# Indo US Bio-Tech Ltd (INDOUS)

Canonical page: https://tapetide.com/stocks/INDOUS

## Company

- **NSE Symbol:** INDOUS
- **BSE Code:** 541304
- **ISIN:** INE250Z01010
- **Sector:** FMCG
- **Industry:** Agricultural Products
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2024-09-27
- **CEO:** Mr. Jagdishkumar Devjibhai Ajudia
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** indousagriseeds.com

## About

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

## Latest Price

- **Price:** ₹78.24
- **Change:** -1.3 (-1.63%)
- **Open:** ₹82
- **Day High:** ₹82
- **Day Low:** ₹78
- **Previous Close:** ₹79.54
- **Volume:** 10159
- **As Of:** 2026-09-11T10:01:39+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:59.588171Z.

- **Market Cap:** ₹158.81 Cr
- **Classification:** Microcap
- **P/E (reported):** 13.6
- **P/E (TTM):** 13.68
- **EPS (TTM):** ₹5.72
- **Book Value:** ₹46.15
- **Price to Book:** 1.68
- **Dividend Yield:** 0.31%
- **ROE:** 13.15%
- **ROCE:** 14.97%
- **Debt to Equity:** 0.4
- **Revenue (yearly):** ₹50.2 Cr
- **Net Income:** ₹5.1 Cr
- **EBITDA:** ₹6.9 Cr
- **52-Week High:** ₹159
- **52-Week Low:** ₹70
- **RSI (14):** 46.02

## Tapetide Score

- **Score:** 46 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 31.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 73.15 | 9% |
| growth | 41.17 | 9% |
| momentum | 13.42 | 12% |
| ownership | 48.26 | 24% |
| quality | 54.15 | 22% |
| valuation | 44.65 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 20.8% CAGR over last 5 years
- Debtor days have improved from 64.6 to 45.5 days.
- Company's median sales growth is 20.7% of last 10 years

### Weaknesses

- Tax rate seems low

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | 421.43% | — |
| ebitda margin growth | 24.24% | 3.44% | 39.27% | — |
| net income growth | 50% | 4.08% | 22% | 21% |
| revenue growth | 27.31% | 24.88% | 22% | 23% |
| roce | 28.19% | -24.74% | -27.51% | — |
| roe | 54.31% | -42.73% | 17.18% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 15.81 | 22.11 | 15.77 | 24.72 | 22.17 | 23.56 | 33.38 | 30.77 | 30.85 | 22.8 | 26.02 | 32.99 |
| Expenses | 13.21 | 17.88 | 14.79 | 21.03 | 17.05 | 18.02 | 28.8 | 25.3 | 26.69 | 18.65 | 22.79 | 29.02 |
| Operating Profit | 2.6 | 4.23 | 0.98 | 3.69 | 5.12 | 5.54 | 4.58 | 5.47 | 4.16 | 4.15 | 3.23 | 3.97 |
| OPM % | 16.45 | 19.13 | 6.21 | 14.93 | 23.09 | 23.51 | 13.72 | 17.78 | 13.48 | 18.2 | 12.41 | 12.03 |
| Other Income | 0 | 0.08 | 0.21 | 0.03 | 0.02 | 0.02 | 0.12 | 0 | 0.03 | 0.01 | 0.02 | 0.12 |
| Interest | 0.41 | 0.37 | 0.36 | 0.33 | 0.52 | 0.38 | 0.26 | 0.45 | 0.42 | 0.77 | 0.6 | 0.74 |
| Depreciation | 0.21 | 0.19 | 0.2 | 0.2 | 0.18 | 0.16 | 0.56 | 0.2 | 0.21 | 0.22 | 0.27 | 0.27 |
| Profit before tax | 1.98 | 3.75 | 0.63 | 3.19 | 4.44 | 5.02 | 3.88 | 4.82 | 3.56 | 3.17 | 2.38 | 3.08 |
| Tax % | 15.66 | 1.87 | 17.46 | 0.63 | 2.03 | -0.8 | 4.9 | 2.49 | 3.09 | 5.36 | 17.23 | 1.3 |
| Net Profit | 1.67 | 3.68 | 0.52 | 3.17 | 4.36 | 5.05 | 3.68 | 4.7 | 3.45 | 3 | 1.97 | 3.04 |
| EPS in Rs | 0.83 | 1.84 | 0.26 | 1.58 | 2.17 | 2.52 | 1.84 | 2.34 | 1.72 | 1.5 | 0.98 | 1.52 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 29 | 35 | 40 | 39 | 49 | 61 | 73 | 104 | 110 | 113 |
| Expenses | 27 | 32 | 36 | 34 | 42 | 51 | 62 | 85 | 93 | 97 |
| Operating Profit | 3 | 3 | 4 | 6 | 7 | 9 | 11 | 19 | 17 | 16 |
| OPM % | 9 | 10 | 10 | 14 | 14 | 15 | 15 | 18 | 15 | 14 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 3 | 3 | 4 | 5 | 7 | 9 | 17 | 14 | 12 |
| Tax % | 29 | 26 | 12 | -23 | 5 | 2 | 6 | 2 | 6 | — |
| Net Profit | 1 | 2 | 3 | 5 | 5 | 7 | 8 | 16 | 13 | 11 |
| EPS in Rs | 1.41 | 1.44 | 1.74 | 3.52 | 2.86 | 3.6 | 4.11 | 8.11 | 6.54 | 5.72 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 3 | 5 | 6 | 6 | 9 | 10 | 20 | 20 | 20 |
| Reserves | 2 | 2 | 9 | 10 | 15 | 30 | 44 | 43 | 58 | 72 |
| Borrowings | 5 | 7 | 6 | 9 | 11 | 12 | 12 | 14 | 15 | 37 |
| Other Liabilities | 4 | 6 | 4 | 10 | 11 | 4 | 3 | 7 | 4 | 4 |
| Total Liabilities | 13 | 17 | 24 | 35 | 44 | 56 | 69 | 84 | 98 | 133 |
| Fixed Assets | 1 | 2 | 1 | 1 | 2 | 6 | 7 | 7 | 10 | 11 |
| CWIP | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 4 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 11 | 16 | 21 | 32 | 39 | 48 | 61 | 74 | 88 | 121 |
| Total Assets | 13 | 17 | 24 | 35 | 44 | 56 | 69 | 84 | 98 | 133 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -1 | -3 | -1 | 0 | 3 | 1 | 2 | 1 | -13 |
| Cash from Investing Activity | 0 | 0 | -3 | -1 | -2 | -5 | -7 | -3 | -1 | -2 |
| Cash from Financing Activity | 0 | 1 | 6 | 2 | 1 | 2 | 6 | 1 | -1 | 20 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 6 |
| Free Cash Flow | 0 | -1 | -4 | -1 | -2 | -1 | -1 | 0 | 1 | -15 |
| CFO/OP | 11 | -16 | -92 | -20 | 6 | 47 | 9 | 23 | 9 | -71 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 76 | 112 | 94 | 193 | 229 | 152 | 148 | 95 | 53 | 45 |
| Inventory Days | 92 | 98 | 176 | 751 | — | — | — | — | — | — |
| Days Payable | 64 | 71 | 34 | 667 | — | — | — | — | — | — |
| Cash Conversion Cycle | 104 | 138 | 236 | 276 | 229 | 152 | 148 | 95 | 53 | 45 |
| Working Capital Days | 34 | 59 | 129 | 137 | 186 | 257 | 285 | 266 | 247 | 248 |
| ROCE % | 14 | 28 | 20 | 17 | 18 | 16 | 15 | 14 | 21 | 14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 68.29% | 68.29% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.18% | 0.01% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 24.52% | 24.4% | 24.43% | 24.42% | 23.8% | 24.21% | 24.34% | 24.36% | 24.14% | 23.69% | 24.46% | 24.51% |
| Others | 5.31% | 5.44% | 5.4% | 5.4% | 6.03% | 5.61% | 5.49% | 5.47% | 5.69% | 6.13% | 7.07% | 7.19% |
| No. of Shareholders | 318 | 1227 | 1183 | 1133 | 780 | 2828 | 2780 | 3112 | 4130 | 4738 | 4531 | 4690 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 78.86 | Sell |
| EMA (10) | 79.38 | Sell |
| SMA (20) | 81.31 | Sell |
| EMA (20) | 80.4 | Sell |
| SMA (50) | 83.28 | Sell |
| EMA (50) | 83.87 | Sell |
| SMA (100) | 90.85 | Sell |
| EMA (100) | 90.9 | Sell |
| SMA (200) | 105.71 | Sell |
| EMA (200) | 105.15 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 39.78 | Neutral |
| MACD (12,26,9) | -1.43 | Buy |
| Stochastic (14,3,3) | 53.67 | Neutral |
| ADX (14) | 34.01 | Buy |
| Williams %R (14) | -44.7 | Neutral |
| ATR (14) | 4.6 | High Volatility |
| ROC (12) | -3.36 | Sell |
| Stoch RSI (14) | 46.56 | Neutral |
| UO (7,14,28) | 42.68 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c046b1a7-ac95-4825-b148-ea6aac8b5bb3.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 05Th September 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4b1fa47-145e-4645-9222-c81747be2278.pdf) |
| 2026-09-05 | [Shareholder Meeting- AGM On Sep 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=671288cf-72b2-4b5c-96bb-824fb8954d46.pdf) |
| 2026-09-05 | [Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76fa6ea-084a-4ff5-990b-0cf48f0b840a.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fe2c513-04c6-4fe9-aad8-3dffcbfba6a3.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a69c71b0-8cf3-4bd7-9e4e-ab79df5a5820.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d15bfd1-0654-4738-b537-3d7128636baf.pdf) |
| 2026-08-05 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11ee8e56-9594-433d-a250-d36a26cda5f2.pdf) |
| 2026-08-05 | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aefbc3a7-0bf5-4705-9fda-a75a61341066.pdf) |
| 2026-08-04 | [Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015; (B) Other Corporate Matters.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=799bbdc9-84c8-41c9-84ae-4b2e177c873b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Results- Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=800a3b0e-e1f8-431d-bfa7-1966155a8ee6.pdf) |
| 2026-05-29 | [Results- Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6576658-1876-4142-bcbd-23421dbcfd72.pdf) |
| 2026-01-21 | [Results- Financial Results For December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e202816c-42ee-4a19-905b-e48a4f275cc9.pdf) |
| 2025-11-14 | [Results-Financial Results For September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=765dc6e8-941f-4e17-9986-efa198d81c59.pdf) |
| 2025-08-12 | [Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3179ea9-ea0c-4fb6-a609-410c4e5a9818.pdf) |
| 2025-02-11 | [Results-Financial Results For December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6614a156-6189-4939-8d2f-3dafebb46d65.pdf) |
| 2024-11-14 | [Results-Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3e200f9-9c08-4cb9-b681-7644dd703701.pdf) |
| 2024-08-08 | [Results-Financial Results For June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b660e79-e771-4bad-89d3-38b4100abb0e.pdf) |
| 2024-05-17 | [Revised Financial Results For The Period Of March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04799aac-271e-477e-ac79-8de11412c3e7.pdf) |
| 2024-05-02 | [Results-Financial Results For March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f030452-9ca9-44f2-8636-89053f1c479f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 30 Apr - Company confirmed it does not meet Large Corporate criteria under SEBI debt circular. | [Non-Applicability Of Large Corporate Criteria As Per SEBI Circular Dated November 26, 2018 30 Apr - Company confirmed it does not meet Large Corporate criteria under SEBI debt circular.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a69d4dc9-4667-4587-a78f-3e87a8a52fbd.pdf) |
| 30 Apr - Company confirmed it does not meet Large Corporate criteria under SEBI debt circular. | [Non-Applicability Of Large Corporate Criteria As Per SEBI Circular Dated November 26, 2018 30 Apr - Company confirmed it does not meet Large Corporate criteria under SEBI debt circular.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a69d4dc9-4667-4587-a78f-3e87a8a52fbd.pdf) |
| 22 Apr - Mrs. Nehaben Sachinbhai Patel resigned as Independent Director effective 21 April 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 22 Apr - Mrs. Nehaben Sachinbhai Patel resigned as Independent Director effective 21 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0960350-e1ff-4757-a45a-243132856e0c.pdf) |
| 22 Apr - Mrs. Hemanshi Darsh Soni appointed Additional Independent Director for 5 years from 21.04.2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 22 Apr - Mrs. Hemanshi Darsh Soni appointed Additional Independent Director for 5 years from 21.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e31e2af6-0ef6-4b0a-8052-ddf240262c28.pdf) |
| 21 Apr - Non-Executive Independent Director Nehaben Patel resigned effective 21 April 2026 due to personal reasons. | [Announcement under Regulation 30 (LODR)-Resignation of Director 21 Apr - Non-Executive Independent Director Nehaben Patel resigned effective 21 April 2026 due to personal reasons.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7d313862-4d81-4019-9c13-8cbacdbb1237.pdf) |
| 21 Apr - Mrs. Nehaben Sachinbhai Patel resigned as Independent Director effective 21 April 2026. | [Resignation Of Mrs. Nehaben Sachinbhai Patel (DIN: 09263180) From The Post Of Independent Director Of The Company. 21 Apr - Mrs. Nehaben Sachinbhai Patel resigned as Independent Director effective 21 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d1553d9-8fa9-4bb4-86d1-36fc64b4ddf4.pdf) |
| 21 Apr - Mrs. Hemanshi Darsh Soni appointed as additional independent director for five years, subject to shareholder approval. | [Announcement under Regulation 30 (LODR)-Change in Directorate 21 Apr - Mrs. Hemanshi Darsh Soni appointed as additional independent director for five years, subject to shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38a36ae8-22f4-4ac1-b17a-8721b34d4bce.pdf) |
| 18 Feb - INDO US AGRISEEDS sold 50,000 INDO US BIO TECH shares (0.2494%) on 17/02/2026; holding now 9.0742%. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 18 Feb - INDO US AGRISEEDS sold 50,000 INDO US BIO TECH shares (0.2494%) on 17/02/2026; holding now 9.0742%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4E2D5099_7FA6_4B3A_97D3_CBAAD68B3CD0_154903.pdf) |
| 11 Mar - Indo Us clarifies no undisclosed information; March 10, 2026 price movement market-driven.; checklist':['Read announcement for context','Assess price-sensitivity and regulatory nature','Assign priority based on guidelines','Provide concise … | [Announcement Under Regulation 30 (LODR)- Clarification On Price Movement 11 Mar - Indo Us clarifies no undisclosed information; March 10, 2026 price movement market-driven.; checklist':['Read announcement for context','Assess price-sensitivity and regulatory nature','Assign priority based on guidelines','Provide concise …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6257be22-f356-4ec6-9b8e-2e732ddaf17d.pdf) |
| 10h - Non-Executive Independent Director Nehaben Patel resigned effective 21 April 2026 due to personal reasons. | [Announcement under Regulation 30 (LODR)-Resignation of Director 10h - Non-Executive Independent Director Nehaben Patel resigned effective 21 April 2026 due to personal reasons.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7d313862-4d81-4019-9c13-8cbacdbb1237.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ebfe8353-9397-4f87-aa0a-d89785eff781.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17569f8e-4eec-47ef-b24f-6036a5ae4d92.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3831b279-1ebd-4173-88fe-59da6fca33eb.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/541304/73618541304.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/541304/71426541304.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/541304/66575541304_01_10_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/541304/5413040319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/541304/5413040318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2017/INDO_US_BIO_TECH_LTD-541304-MARCH-2017.PDF) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:30.271Z.